Breast Cancer

Living with the challenges of having a BRCA1 gene mutation, a woman faces a different struggle when she discovers that diagnosis was wrong.

Here are the top 5 CURE stories for May 2019.

The addition of Kisqali to standard-of-care endocrine therapy significantly improved overall survival for premenopausal women with advanced HR-positive/HER2-negative breast cancer compared with endocrine therapy alone.

This essay nominating Cindy Trawick, ARNP, FNP-BC for CURE®'s Extraordinary Healer® Award was written by Sandy Allten, RN, OCN, CCRP, of AdventHealth Cancer Institute and Charlene’s Dream.

A mother-daughter duo participates in the Donna Foundation’s marathon weekend to fund breast cancer research and support patients.

A male breast cancer survivor shares a note of gratitude to his surgeon.

As a cancer survivor and advocate, I have gotten the calls that we survivors hate: calls from someone we don’t know who says that a mutual friend told them to call, and friends saying they have been received a diagnosis. I am always ready when the phone rings.

"I wholeheartedly recommend Betsy Loop for the 2019 CURE® Extraordinary Healer® Award because that is a perfect description of her: extraordinary and a healer of the body, of the mind and, most important, of the spirit. She deserves to be recognized as a very special person and nurse — and one I have been blessed to know," wrote Carol Schumacher.

Exercises specifically designed for breast cancer survivors are helpful after surgery and years out, if we remember to do them!

The Food and Drug Administration has approved the PI3K inhibitor Piqray (alpelisib) for the treatment of postmenopausal women, and men, with HR-positive, HER2-negative, PIK3CA-mutated, advanced or metastatic breast cancer following progression on or after an endocrine-based regimen.

From World Blood Cancer Day to today’s top performers fundraising for lifesaving research, here’s what’s making headlines in the cancer space this week.

When you are lost you ask, "Where am I?" When you go through cancer, it is hard to find where you are. In the map of life, why not find yourself where you are in this very moment? You are here.

Two oncology dietitians weigh in on the results of a recent study that show a low-fat diet rich in fruits, vegetables and grains can reduce the risk of dying from breast cancer.

A two-time cancer survivor finds cancer worries a little easier to face with time and experience.

Patients who self-report their symptoms live longer than those who do not, researchers say. Here’s why and what it means for the future of cancer treatment.

Stephanie Seban explains the hurdles she faced as she received the wrong treatment for nearly five years.

Lorén Barbosa, co-chairperson of More Than Friends, discussed the Latino/Caribbean/American organization's Annual Tea Party and the their goal of sending a message of overall health and wellness.

A breast cancer survivor remembers an inconvenient Mother’s Day phone call as he celebrates five years of being cancer-free.

Breast cancer survivors may find symptom relief through at-home acupressure, according to study findings.

In this episode of CURE® Talks Cancer, we spoke with an advocate who is raising awareness around the recent controversy surrounding a certain type of breast implant that is causing a rare type of lymphoma.

More Than Friends chairperson Elise Bourne-Busby talked about her breast cancer journey and the inspiration for the Latino/Caribbean/American initiative that is dedicated to servicing cancer survivors.

At 42,000 US deaths a year, the push to call metastatic breast cancer "chronic" is premature.

The FDA approved Kadcyla for adjuvant treatment of patients with HER2-positive early breast cancer who have residual invasive disease after neoadjuvant taxane and Herceptin-based treatment.

Here are the top 5 CURE stories for April 2019.

Researchers examined the prevalence of chronic opioid use among survivors of breast, colorectal and lung cancer.